Published in Eur Respir J on March 01, 1998
Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. Thorax (2000) 2.10
Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study. Am J Respir Crit Care Med (2006) 1.59
Beta-agonists and asthma: too much of a good thing? J Clin Invest (2003) 1.20
Asthma genetics and personalised medicine. Lancet Respir Med (2014) 1.17
Pharmacogenetics of asthma. Curr Opin Pulm Med (2009) 0.99
Pharmacogenetics of asthma. Br J Clin Pharmacol (2002) 0.93
Management of asthma in adults: current therapy and future directions. Postgrad Med J (2003) 0.88
Beta2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells. Thorax (2002) 0.86
Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment. Yonsei Med J (2009) 0.85
New approaches to managing asthma: a US perspective. Ther Clin Risk Manag (2008) 0.81
Pharmacogenetics, pharmacogenomics and airway disease. Respir Res (2001) 0.81
A novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2-adrenergic receptor internalization and down-regulation. FASEB J (2012) 0.81
Pharmacogenetics of the beta 2-adrenergic receptor gene. Immunol Allergy Clin North Am (2007) 0.79
Limited beta2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics. Respir Res (2006) 0.78
Asthma in sickle cell disease: implications for treatment. Anemia (2011) 0.75
Evaluation of spirometry values in relation to beta-2-adrenergic receptor gene polymorphism. Eur J Med Res (2010) 0.75
Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics. Inflammation (2015) 0.75
Regular inhaled beta-agonist treatment in bronchial asthma. Lancet (1990) 9.93
Asthma mortality in New Zealand: a two year national study. N Z Med J (1985) 4.60
Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature (1990) 3.80
The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med (2001) 3.35
A comparison of active and simulated chiropractic manipulation as adjunctive treatment for childhood asthma. N Engl J Med (1998) 3.29
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Making the diagnosis of asthma. BMJ (1997) 3.01
International trends in asthma mortality: 1970 to 1985. Chest (1988) 2.97
Accuracy of certification of deaths due to asthma. A national study. Am J Epidemiol (1986) 2.74
What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J (2001) 2.65
Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol Cell Biol (1998) 2.39
Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology (1999) 2.33
Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med (1996) 2.18
Effects of cannabis on lung function: a population-based cohort study. Eur Respir J (2009) 2.16
Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax (2004) 2.13
Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med (2000) 1.93
T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med (1998) 1.91
The respiratory effects of cannabis dependence in young adults. Addiction (2000) 1.89
Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med (2000) 1.87
Prevalence of asthma, rhinitis and eczema among children in 2 Canadian cities: the International Study of Asthma and Allergies in Childhood. CMAJ (1999) 1.84
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur Respir J (2003) 1.84
Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children. Thorax (1986) 1.76
75 deaths in asthmatics prescribed home nebulisers. Br Med J (Clin Res Ed) (1987) 1.72
Asthma mortality: comparison between New Zealand and England. Br Med J (Clin Res Ed) (1986) 1.69
Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J (2000) 1.69
Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J Mol Biol (1995) 1.64
Exacerbations of asthma without sputum eosinophilia. Thorax (1995) 1.63
The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology. Drug Saf (1994) 1.60
Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure. Circulation (1973) 1.57
Regular beta-adrenergic agonists. Evidence, not reassurance, is what is needed. Chest (1994) 1.55
Childhood asthma in New Zealand. Br J Dis Chest (1987) 1.54
Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax (1993) 1.53
Asthma exacerbations . 1: epidemiology. Thorax (2006) 1.48
Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics. Eur Respir J (1997) 1.46
Predicting steroid responsiveness in patients with asthma using exhaled breath profiling. Clin Exp Allergy (2013) 1.44
Local population structure and sex ratio: evolution in gynodioecious plants. Am Nat (1997) 1.44
Forceps birth delivery, allergic sensitisation and asthma: a population-based cohort study. Clin Exp Allergy (2013) 1.43
Deleterious effects of inhaled beta-agonists: short-acting and long-acting agents differ. Chest (2001) 1.42
Sheepskins and bedding in childhood, and the risk of development of bronchial asthma. Aust N Z J Med (1994) 1.40
Water-saline controversy or deficient regional anesthesia training? Anesth Analg (1994) 1.39
Trends in asthma mortality in young people in southern Brazil. Ann Allergy Asthma Immunol (1999) 1.39
Asthma deaths in New Zealand. Lancet (1995) 1.39
Beta-agonists and bronchial asthma. Chest (1993) 1.39
Genomic admixture increases fitness during a biological invasion. J Evol Biol (2010) 1.37
Deaths from asthma in New Zealand. Arch Dis Child (1986) 1.36
Associations between birth weight, early childhood weight gain and adult lung function. Thorax (2008) 1.35
Prevalence of asthma symptoms among adults aged 20-44 years in Canada. CMAJ (2001) 1.33
Intravenous nitroglycerin in acute myocardial infarction. Circulation (1975) 1.32
The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Am Rev Respir Dis (1985) 1.31
Investigation of diurnal changes in the disposition of theophylline. Br J Clin Pharmacol (1983) 1.29
The effect of adiposity measured by dual-energy X-ray absorptiometry on lung function. Eur Respir J (2008) 1.28
Lessons from the national asthma mortality study: circumstances surrounding death. N Z Med J (1987) 1.26
Asthma morbidity and mortality: New Zealand. J Allergy Clin Immunol (1987) 1.25
Relationship between fetal growth and the development of asthma and atopy in childhood. Thorax (1999) 1.23
Longitudinal effects of passive smoking on pulmonary function in New Zealand children. Am Rev Respir Dis (1992) 1.23
Relationships of bronchial responsiveness assessed by methacholine to serum IgE, lung function, symptoms, and diagnoses in 11-year-old New Zealand children. J Allergy Clin Immunol (1992) 1.20
Asthma in seven year old children: a report from the Dunedin Multidisciplinary Child Development Study. N Z Med J (1982) 1.20
Patients at risk for dying of asthma: New Zealand experience. J Allergy Clin Immunol (1987) 1.20
Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med (1998) 1.19
How should we construct psychiatric family history scores? A comparison of alternative approaches from the Dunedin Family Health History Study. Psychol Med (2008) 1.18
Elevated B cells in sputum of asthmatics. Close correlation with eosinophils. Am J Respir Crit Care Med (1996) 1.16
Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease. Br J Clin Pharmacol (1984) 1.15
The validity of the family history screen for assessing family history of mental disorders. Am J Med Genet B Neuropsychiatr Genet (2009) 1.15
Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J (2002) 1.14
Occupational asthma in adults in six Canadian communities. Am J Respir Crit Care Med (2000) 1.13
Geographical variations in the prevalence of atopic sensitization in six study sites across Canada. Allergy (2010) 1.11
Thiazolinone analogues of indolmycin with antiviral and antibacterial activity. J Med Chem (1978) 1.10
Reduced selenium in asthmatic subjects in New Zealand. Thorax (1990) 1.09
Hemodynamic and prognostic findings in patients with transmural and nontransmural infarction. Circulation (1975) 1.09
Right ventricular dysfunction detected by gated scintiphotography in patients with acute inferior myocardial infarction. Circulation (1975) 1.08
Relations of bronchial responsiveness to allergy skin test reactivity, lung function, respiratory symptoms, and diagnoses in thirteen-year-old New Zealand children. J Allergy Clin Immunol (1995) 1.07
Infant gut microbiota and food sensitization: associations in the first year of life. Clin Exp Allergy (2015) 1.07
Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma. Qual Life Res (1997) 1.06
Sex ratio variance and the maintenance of environmental sex determination. J Evol Biol (2007) 1.05
Relationship between socioeconomic status and asthma: a longitudinal cohort study. Thorax (2004) 1.05
Pulmonary alveolar microlithiasis. Thorax (1971) 1.03
Pulmonary artery sarcoma mimicking pulmonary embolism. Chest (1993) 1.02
Bronchodilator tolerance: the impact of increasing bronchoconstriction. Eur Respir J (2003) 1.01
Tolerance to beta-agonists during acute bronchoconstriction. Eur Respir J (1999) 1.01
The beta-agonist controversy. Med Clin North Am (1996) 1.00
Relation of the course of bronchial responsiveness from age 9 to age 15 to allergy. Am J Respir Crit Care Med (1995) 0.99
The role of furosemide in the treatment of left ventricular dysfunction associated with acute myocardial infarction. Circulation (1973) 0.99
Myocardial-infarct extension detected by precordial ST-segment mapping. N Engl J Med (1974) 0.98
Bronchodilator treatment in asthma. BMJ (1993) 0.98
Acral lentiginous melanoma. Cutis (1980) 0.98
Use of anti-asthma drugs in New Zealand. Thorax (1987) 0.97
Measuring asthma control: a comparison of three classification systems. Eur Respir J (2010) 0.96
Asthma mortality: a review of recent experience in New Zealand. J Allergy Clin Immunol (1987) 0.95
Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation. Br J Clin Pharmacol (1982) 0.94
Why are deaths from asthma increasing? Eur J Respir Dis Suppl (1986) 0.93
Growing up with asthma. BMJ (1994) 0.93
Physical exercise and resistive breathing training in severe chronic airways obstruction--are they effective? Eur J Respir Dis (1985) 0.92
Craniofacial form and obstructive sleep apnea in Polynesian and Caucasian men. Sleep (2000) 0.91
A case report of obstructive sleep apnea in a patient with bipolar affective disorder. Can J Psychiatry (1985) 0.91
Patient compliance with oral theophylline therapy. Br J Clin Pharmacol (1984) 0.90
The effects of airway hyperresponsiveness, wheezing, and atopy on longitudinal pulmonary function in children: a 6-year follow-up study. Pediatr Pulmonol (1992) 0.90
A case of melorheostosis with associated linear cutaneous vascular malformation. Clin Exp Dermatol (1981) 0.90